AJP - Heart Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 295: H1817-H1824, 2008. First published September 19, 2008; doi:10.1152/ajpheart.00472.2008
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/5/H1817    most recent
00472.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, K.
Right arrow Articles by Zhang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, K.
Right arrow Articles by Zhang, H.

REVIEW

Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases

Kieran Quinn,1,2,3,4 Melanie Henriques,1,2,3,4 Tom Parker,1,3 Arthur S. Slutsky,1,4 and Haibo Zhang1,2,3,4

1The Keenan Research Centre in the Li Ka Shing Knowledge Institute of Saint Michael's Hospital; and 2Departments of Anaesthesia and Physiology, 3Cardiovascular Sciences Collaborative Program, 4Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada

ABSTRACT

The traditional view of atherosclerosis has recently been expanded from a predominantly lipid retentive disease to a coupling of inflammatory mechanisms and dyslipidemia. Studies have suggested a novel role for polymorphonuclear neutrophil (PMN)-dominant inflammation in the development of atherosclerosis. Human neutrophil peptides (HNPs), also known as {alpha}-defensins, are secreted and released from PMN granules upon activation and are conventionally involved in microbial killing. Current evidence suggests an important immunomodulative role for these peptides. HNP levels are markedly increased in inflammatory diseases including sepsis and acute coronary syndromes. They have been found within the intima of human atherosclerotic arteries, and their deposition in the skin correlates with the severity of coronary artery diseases. HNPs form complexes with LDL in solution and increase LDL binding to the endothelial surface. HNPs have also been shown to contribute to endothelial dysfunction, lipid metabolism disorder, and the inhibition of fibrinolysis. Given the emerging relationship between PMN-dominant inflammation and atherosclerosis, HNPs may serve as a link between them and as a biological marker and potential therapeutic target in cardiovascular diseases including coronary artery diseases and acute coronary syndromes.

{alpha}-defensins; inflammation; cytokine


Address for reprint requests and other correspondence: H. Zhang, Rm. 7-007, Queen Wing, 30 Bond St., Toronto, ON M5B 1W8, Canada (e-mail: zhangh{at}smh.toronto.on.ca)




This article has been cited by other articles:


Home page
 CirculationHome page
T. N. Mayadas, G. C. Tsokos, and N. Tsuboi
Mechanisms of Immune Complex-Mediated Neutrophil Recruitment and Tissue Injury
Circulation, November 17, 2009; 120(20): 2012 - 2024.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.